Related Experiment Videos
Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study
Kaisa Saari1, Hannu Koponen, Jaana Laitinen
1Department of Psychiatry, University of Oulu, 90014 Oulu, Finland.
The Journal of Clinical Psychiatry
|May 4, 2004
Summary
Antipsychotic medication use is linked to elevated cholesterol and triglyceride levels, even in young adults. Regular monitoring and lifestyle interventions are recommended for individuals on these drugs to manage hyperlipidemia risk.
Area of Science:
- Pharmacology
- Cardiovascular Health
- Psychiatry
Background:
- Phenothiazines and atypical antipsychotics are known to elevate serum triglyceride and cholesterol levels.
- Previous research on antipsychotic-associated hyperlipidemia primarily utilized clinical samples, often from case series.
- This study investigates hyperlipidemia prevalence in a general population-based birth cohort, comparing users and non-users of antipsychotic medication.
Purpose of the Study:
- To determine the prevalence of hyperlipidemia in individuals using antipsychotic medication compared to those not using it.
- To assess the association between antipsychotic use (typical and atypical) and lipid levels in a general population sample.
- To evaluate the risk of hypercholesterolemia, hypertriglyceridemia, and high LDL cholesterol associated with antipsychotic use.
Main Methods:
- Analysis of 5654 members of the Northern Finland 1966 Birth Cohort examined at age 31.
- Measurement of serum total cholesterol, HDL cholesterol, LDL cholesterol, and triglyceride levels after an overnight fast.
- Logistic regression analysis adjusted for risk factors to assess the impact of antipsychotic medication on lipid levels.
Main Results:
- Individuals using antipsychotic medication exhibited higher prevalence of hypercholesterolemia (31.1%), high LDL cholesterol (20.0%), and hypertriglyceridemia (22.2%) compared to non-users (12.2%, 10.2%, 7.0%).
- Adjusted logistic regression revealed increased risks for hypercholesterolemia (2.8-fold) and hypertriglyceridemia (2.3-fold) in antipsychotic users.
- Elevated lipid levels were observed even in young adults treated with typical or atypical antipsychotics.
Conclusions:
- Antipsychotic medication use is associated with an elevated, independent risk of hyperlipidemia.
- Individuals on antipsychotic treatment, even at a young age, are at increased risk for lipid abnormalities.
- Regular monitoring of lipid levels and consideration of dietary changes or medication are advised for patients using antipsychotics.